TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A study tracking 316,542 adults in South Korea found that very low hemoglobin, and in some analyses very high hemoglobin, was associated with a higher likelihood of later dementia diagnoses. The researchers say the observational results do not prove hemoglobin causes dementia and should not prompt people to change levels or take supplements to prevent it.
A study of 316,542 adults in South Korea found that hemoglobin levels measured in routine health screenings were associated with dementia diagnoses recorded over as long as 15 years. The observational research, presented at the ECNP Congress in Munich and published in the Journal of Alzheimer’s Disease, suggests a common blood-test result may help researchers study long-term brain health, but it does not show that hemoglobin levels cause dementia or predict an individual person’s future.
The participants were aged 40 and older and had a national health screening in 2004 or 2005. Researchers grouped them into five categories according to hemoglobin levels, from the lowest fifth to the highest fifth, then used national health insurance records to identify new dementia diagnoses through the end of 2019. The study reports associations between those categories and later diagnoses; it does not establish that changing a person’s hemoglobin would change their dementia risk.
Compared with the study’s reference group, people in the lowest hemoglobin fifth had a 16% higher risk of all-cause dementia, while those in the highest fifth had a 7% higher risk. For Alzheimer’s disease, the increase was mainly seen in the lowest fifth, which had a 14% higher risk than the reference group. For vascular dementia, the lowest fifth had a 19% higher risk and the highest fifth an 18% higher risk. The pattern for vascular dementia did not rise or fall consistently across all five groups.
The researchers also reported that the association was clearer and more consistent among women than men. Hemoglobin is a protein in red blood cells that carries oxygen around the body. Low levels are commonly associated with anemia; unusually high levels can have several possible explanations, including smoking, dehydration, and lung or heart disease. The study does not establish which, if any, of these factors explains the observed associations.
What Routine Blood Counts Could Reveal
Hemoglobin is already measured in many routine blood tests, making it an accessible marker for further research compared with specialist scans or newer biomarkers. The results may help investigators examine how general physical health and brain health are related over time. They do not show that a routine test can diagnose dementia, reliably forecast an individual’s outcome, or identify a proven way to prevent the condition.
Lead researcher Dr. Hyun Soo Kim, an assistant professor at Dong-A University College of Medicine in Busan, said dementia is a growing challenge in aging societies and that accessible markers could help researchers and clinicians understand links between whole-body health and the brain. That is a research rationale, not evidence that treating an abnormal hemoglobin result prevents dementia. The study authors specifically cautioned against interpreting their findings as a reason to take iron supplements or to try to raise or lower hemoglobin for dementia prevention.
For readers, the practical distinction is between an association at the population level and personal medical guidance. An unusual result can have many explanations and should be discussed with a clinician who can assess it in context. The study does not support changing treatment or supplement use based on dementia concerns alone.
As an affiliate, we earn on qualifying purchases.
How Researchers Tracked Dementia Diagnoses
The analysis drew on a large national cohort whose participants had screening examinations in 2004–2005. Researchers then connected screening data with national health insurance records to track new diagnoses through December 2019, giving some participants up to 15 years of follow-up. The design allowed the team to compare later recorded diagnoses across five hemoglobin groups.
Because the study was observational, it can show that measured hemoglobin levels and later diagnoses occurred together more often in certain groups, but it cannot establish why. Other health conditions or shared risk factors may contribute. The researchers also noted that early dementia processes, before diagnosis, might affect nutrition, frailty, weight loss, or anemia and thus influence hemoglobin levels. This possibility means the direction of the relationship is not settled.
Dr. Lindsey Sinclair of the University of Southampton, commenting on the findings, said evidence increasingly points to connections between physical and brain health. She also said further work is needed to establish whether the link applies to people from a wider range of backgrounds and what might reduce risk among people with very low or high hemoglobin. The current study involved a Korean cohort, so its results should not automatically be treated as representative of every population.
“The findings do not show that hemoglobin itself causes dementia, but suggest that abnormal hemoglobin levels may be a visible marker of wider physical vulnerability relevant to brain health.”
— Dr. Hyun Soo Kim, lead researcher and assistant professor at Dong-A University College of Medicine
As an affiliate, we earn on qualifying purchases.
Limits of the Hemoglobin Findings
The study cannot determine whether hemoglobin levels themselves contribute to dementia, reflect other health conditions, or are affected by early changes that precede diagnosis. The authors also did not establish a biological mechanism explaining why the associations differed by dementia type or appeared clearer among women. The vascular dementia results, in particular, did not follow a simple pattern across all five groups.
It is also unclear whether the findings would be similar in populations with different backgrounds, health systems, or demographic characteristics. The report does not provide a clinical threshold that could be used to estimate an individual’s dementia risk from a routine blood result, and it does not test an intervention to reduce risk. The reported percentages are comparisons between study groups, not a prediction of any one person’s chance of developing dementia.
As an affiliate, we earn on qualifying purchases.
Further Research on Risk and Prevention
Further studies will be needed to test whether the association appears in people from a wider range of backgrounds and to clarify how hemoglobin, underlying health, and dementia may be related. Researchers would also need to investigate whether addressing particular health conditions changes later dementia outcomes; this study did not test that question.
For now, the findings are a research observation, not a screening recommendation or prevention plan. Anyone with an abnormal hemoglobin result should discuss it with a qualified health professional, as Dr. Kim advised, rather than trying to alter levels or use supplements to affect dementia risk. The next milestone is additional evidence that can distinguish correlation from cause and assess whether the finding has practical clinical value.
As an affiliate, we earn on qualifying purchases.
Key Questions
Does a routine hemoglobin test diagnose dementia?
No. This study found group-level associations between hemoglobin categories and later recorded diagnoses. It did not test hemoglobin as a diagnostic tool or show that a result can predict whether a particular person will develop dementia.
What did the study find about low and high hemoglobin?
The lowest fifth of participants had a 16% higher risk of all-cause dementia than the reference group, and the highest fifth had a 7% higher risk. Associations varied by dementia type: both the lowest and highest fifths had higher reported risk of vascular dementia, while the Alzheimer’s association was mainly seen in the lowest fifth.
Should people take iron to reduce dementia risk?
No prevention benefit was established. The study authors said the results should not be taken as advice to use iron supplements or to raise or lower hemoglobin to prevent dementia. Discuss an abnormal result with a qualified health professional.
Why are more studies needed?
The research was observational and involved a Korean cohort, so it cannot prove cause and effect or show whether the findings apply to other populations. Further work is needed to examine possible explanations and whether the association has practical value for care.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
